|Bid||94.70 x 900|
|Ask||95.00 x 1100|
|Day's Range||91.52 - 95.66|
|52 Week Range||66.59 - 117.35|
|Beta (5Y Monthly)||0.26|
|PE Ratio (TTM)||31.44|
|Forward Dividend & Yield||1.47 (1.39%)|
|Ex-Dividend Date||Aug 16, 2021|
|1y Target Est||116.60|
Investment company DDD Partners, LLC (Current Portfolio) buys Intel Corp, Novo Nordisk A/S, Broadcom Inc, DocuSign Inc, Atlas Corp, sells Adaptive Biotechnologies Corp, Editas Medicine Inc, Magna International Inc, Activision Blizzard Inc, Gentex Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, DDD Partners, LLC.
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 24 January 2022 – On 5 November 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period
Investment company Paces Ferry Wealth Advisors, Llc (Current Portfolio) buys Sprinklr Inc, Schwab U.S.